Seah H. Lim - 01 Feb 2024 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EMMA	Options	Award	$15,000	+100,000		$0.15	100,000	01 Feb 2024	Common Stock	100,000	$0.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options vest in four equal installments as of the last day of each quarter beginning on March 31, 2024